KBC Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Sell |
3,470
-1,903
| -35% | -$63.1K | ﹤0.01% | 1112 |
|
|
2025
Q1 | $216K | Buy |
5,373
+239
| +5% | +$9.61K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $242K | Buy |
5,134
+1,902
| +59% | +$89.7K | ﹤0.01% | 1032 |
|
|
2024
Q3 | $171K | Buy |
3,232
+851
| +36% | +$45K | ﹤0.01% | 999 |
|
|
2024
Q2 | $129K | Buy |
2,381
+362
| +18% | +$19.6K | ﹤0.01% | 1045 |
|
|
2024
Q1 | $142K | Sell |
2,019
-327
| -14% | -$23K | ﹤0.01% | 968 |
|
|
2023
Q4 | $196K | Hold |
2,346
| – | – | ﹤0.01% | 848 |
|
|
2023
Q3 | $69K | Sell |
2,346
-5,080
| -68% | -$149K | ﹤0.01% | 1192 |
|
|
2023
Q2 | $242K | Sell |
7,426
-427
| -5% | -$13.9K | ﹤0.01% | 885 |
|
|
2023
Q1 | $276K | Hold |
7,853
| – | – | ﹤0.01% | 886 |
|
|
2022
Q4 | $360K | Hold |
7,853
| – | – | ﹤0.01% | 809 |
|
|
2022
Q3 | $380K | Buy |
7,853
+1,374
| +21% | +$66.5K | ﹤0.01% | 811 |
|
|
2022
Q2 | $255K | Buy |
6,479
+3,794
| +141% | +$149K | ﹤0.01% | 919 |
|
|
2022
Q1 | $99K | Buy |
+2,685
| New | +$99K | ﹤0.01% | 1193 |
|